CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Repare Therapeutics Inc.

    CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Repare Therapeutics Inc.

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s

Read Full Article

Lumira Capital leads $9.0M Series A expansion for Vascular Pharmaceuticals

    Lumira Capital leads $9.0M Series A expansion for Vascular Pharmaceuticals

Vascular Pharmaceuticals, Inc. (VPI), a clinical-stage pharmaceutical company addressing the complications of diabetes, announced that it has increased its Series A financing with the addition of a $9 million expansion

Read Full Article

SIGN UP FOR DAILY DEALS AND NEWS UPDATE

CVCA Events

CVCA on Twitter